RaySearch Showcases Cutting-Edge Innovations at ASTRO 2025 Conference

RaySearch Showcases Cutting-Edge Innovations at ASTRO 2025 Conference



RaySearch Laboratories AB (publ) is set to participate in the upcoming ASTRO conference from September 28-30, 2025, in San Francisco, California. This event promises to be a pivotal moment in the world of oncology as RaySearch introduces groundbreaking innovations under the theme "Coding Energy to End Cancer." Visitors can expect to see demonstrations of key products such as RayStation®, RayCare®, and RayIntelligence® at booth #2025 and on the event's webpage.

Key Focus Areas


At ASTRO 2025, RaySearch will focus on five critical areas that are essential for the future of cancer care:

1. Adaptive Radiotherapy: This approach allows clinicians to personalize and adjust treatments for patients as their therapy progresses.
2. Automated Workflows: By enhancing efficiency and quality, these workflows simplify complex processes in treatment planning.
3. Integrated Planning: This ensures seamless connections between systems and data for effective treatment planning.
4. Analyzing Clinical Data: RaySearch will demonstrate how to transform fragmented clinical information into actionable insights.
5. Uniting Industry: In collaboration with industry leaders like IBA, Vision RT, GE Healthcare, and C-RAD, RaySearch aims to foster vendor-agnostic partnerships that drive innovation in oncology care.

RaySearch also takes pride in being a member of UniteRT, an initiative focused on promoting open collaboration among industry players. For those interested, detailed information on UniteRT can be found on their website.

Booth Highlights


Attendees at the RaySearch booth can expect to see:
  • - The latest advancements in RayStation, including features like high-speed adaptive replanning, upright treatment planning, AI-driven image segmentation, and enhanced automation with state-of-the-art algorithms.
  • - The introduction of ECHO, a new automated planning algorithm developed by the prestigious Memorial Sloan Kettering Cancer Center, which is now fully integrated into RayStation.
  • - A revamped Plan Explorer module, designed for comprehensive exploration and comparison of treatment options across various modalities.
  • - RayCare will showcase its innovative approach to oncology workflows, orchestrating every step of patient management from diagnosis through treatment to follow-up care.
  • - RayIntelligence will highlight its capabilities as a cloud-based analytics system that consolidates data from RayStation and RayCare, providing insights for better clinical decision-making. Visitors can explore dashboards that summarize treatment planning, clinic operations, and performance metrics.
  • - RaySearch will also introduce µ-RayStation®, a platform dedicated to small animal irradiation research, aimed at enhancing preclinical studies.

A Vision for the Future


Johan Löf, the founder and CEO of RaySearch, emphasized the company's commitment to improving cancer care, stating, "We believe the future of cancer care lies in intelligent, unified systems that redefine what's possible. At ASTRO 2025, RaySearch is proud to be among the global leaders driving this transformation, empowering clinics to provide more personalized, efficient, and impactful treatment than ever before."

About RaySearch


RaySearch Laboratories AB (publ) is a pioneering medical technology firm dedicated to developing innovative software solutions aimed at enhancing cancer treatment. With over 1,100 clinics across 47 countries using their products, RaySearch has established a reputation for excellence in the field. Their flagship products include the RayStation® treatment planning system and the RayCare® oncology information system, along with newer offerings like RayIntelligence® and RayCommand®. RaySearch was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and has been publicly listed on Nasdaq Stockholm since 2003 (STO RAY B). More information can be found at raysearchlabs.com.

Note: Some functionalities may differ by region due to regulatory clearances. Please check with your local vendor for detailed information.

For additional inquiries, contact Johan Löf or Matt Miley at RaySearch Laboratories. Their commitment to innovation in oncology continues to pave the way for more effective cancer treatment solutions.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.